SOURCE-LINKED STUDY SUMMARY
HIF-1 plays a dual regulatory role in hippocampal neuronal PANoptosis in Alzheimer's disease via the HK2/VDAC1/NLRP3 axis and RIPK3 signaling.
Abstract summarizedQuality not appraised
- What was studied
- Researchers investigated a combined cell-death process in an Alzheimer's disease mouse model, including how semaglutide affects the process.
- Who / model studied
- The experiments concerned hippocampal neurons in a mouse model. The abstract does not state sample size, sex, comparison regimen or treatment duration.
- Studied dose & schedule
- Dose and schedule have not yet been extracted for this summary.
- What the study found
- A cellular signaling pathway both promoted and restrained neuron-death mechanisms. Researchers report that semaglutide shifted this signaling and reduced the combined cell-death process. The abstract gives no effect sizes or cognitive-outcome results.
- Limitations & context
- Study limitations were not stated in the abstract. Methodological quality has not been appraised.
Read summary source ↗ · Prepared 9/15/2026 · AI-assisted, source-based summary
Review record & corrections
Summary prepared: . Source scope: abstract. This is an AI-assisted source summary, not an independent clinician sign-off.
No public field-by-field revision history is available for this card yet. The date above is the summary date, not proof that every field was updated then.
Inspect the source · Correction policyResearch findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.
Original publication ↗ · DOI: 10.1016/j.phrs.2026.108440